pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens.

Journal: Cancer immunology research
Published Date:

Abstract

Identification of neoantigens is a critical step in predicting response to checkpoint blockade therapy and design of personalized cancer vaccines. This is a cross-disciplinary challenge, involving genomics, proteomics, immunology, and computational approaches. We have built a computational framework called pVACtools that, when paired with a well-established genomics pipeline, produces an end-to-end solution for neoantigen characterization. pVACtools supports identification of altered peptides from different mechanisms, including point mutations, in-frame and frameshift insertions and deletions, and gene fusions. Prediction of peptide:MHC binding is accomplished by supporting an ensemble of MHC Class I and II binding algorithms within a framework designed to facilitate the incorporation of additional algorithms. Prioritization of predicted peptides occurs by integrating diverse data, including mutant allele expression, peptide binding affinities, and determination whether a mutation is clonal or subclonal. Interactive visualization via a Web interface allows clinical users to efficiently generate, review, and interpret results, selecting candidate peptides for individual patient vaccine designs. Additional modules support design choices needed for competing vaccine delivery approaches. One such module optimizes peptide ordering to minimize junctional epitopes in DNA vector vaccines. Downstream analysis commands for synthetic long peptide vaccines are available to assess candidates for factors that influence peptide synthesis. All of the aforementioned steps are executed via a modular workflow consisting of tools for neoantigen prediction from somatic alterations (pVACseq and pVACfuse), prioritization, and selection using a graphical Web-based interface (pVACviz), and design of DNA vector-based vaccines (pVACvector) and synthetic long peptide vaccines. pVACtools is available at http://www.pvactools.org.

Authors

  • Jasreet Hundal
    The Genome Institute, Washington University in St. Louis, St. Louis, Missouri, United States of America.
  • Susanna Kiwala
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
  • Joshua McMichael
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Christopher A Miller
    The Genome Institute, Washington University in St. Louis, St. Louis, Missouri, United States of America.
  • Huiming Xia
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Alexander T Wollam
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Connor J Liu
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Sidi Zhao
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Yang-Yang Feng
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Aaron P Graubert
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Amber Z Wollam
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
  • Jonas Neichin
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Megan Neveau
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Jason Walker
    McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • William E Gillanders
    Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Elaine R Mardis
    The Genome Institute, Washington University in St. Louis, St. Louis, Missouri, United States of America; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America; Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
  • Obi L Griffith
    The Genome Institute, Washington University in St. Louis, St. Louis, Missouri, United States of America; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
  • Malachi Griffith
    The Genome Institute, Washington University in St. Louis, St. Louis, Missouri, United States of America; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America.